Home › Calculator › MPLT Dividend Calculator 2026
MPLT Dividend DRIP Calculator 2026
5.09% YieldHealthcareMapLight Therapeutics, Inc. · NASDAQ
Price: $39.32 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MPLT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MPLT snowball 📈
$10,000 in MPLT → $16.4K in 10 years · $66.25/month
About MapLight Therapeutics, Inc. (MPLT) — Dividend Analysis 2026
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.
Compare MPLT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MPLT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MPLT position with:
🌍 MPLT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MPLT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.09% | 2.29% | $509 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.33% | 1.53% | $433 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.07% | 1.27% | $407 / yr |
| 🇬🇧 UK ISA | 0% | 5.09% | 2.29% | $509 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.64% | 1.84% | $464 / yr |
| 🇨🇦 TFSA | 0% | 5.09% | 2.29% | $509 / yr |
| 🇨🇦 CA Taxable | 25% | 3.82% | 1.02% | $382 / yr |
| 🇦🇺 Super (pension) | 15% | 4.33% | 1.53% | $433 / yr |
| 🇦🇺 AU Taxable | 30% | 3.56% | 0.76% | $356 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.75% | 0.95% | $375 / yr |
| 🇫🇷 FR Taxable | 30% | 3.56% | 0.76% | $356 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MPLT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MPLT Dividend Payment Schedule
MPLT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MPLT vs Healthcare Benchmarks
How MPLT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MPLT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MPLT Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MPLT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
MapLight Therapeutics, Inc. (MPLT) is currently trading at $39.32, trading near its 52-week high. The current dividend yield is 5.09% based on an annual payout of $2.00 per share.
MPLT (MapLight Therapeutics, Inc.) — 5.09% Dividend Yield Analysis
MapLight Therapeutics, Inc. (MPLT) is a healthcare stock currently trading at $39.32 with a dividend yield of 5.09%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest MPLT News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.